Rank
|
Page title
|
Views
|
Daily average
|
Assessment
|
Importance
|
1
|
COVID-19 pandemic
|
208,514
|
6,950
|
GA
|
Top
|
2
|
Norovirus
|
149,439
|
4,981
|
B
|
Top
|
3
|
COVID-19
|
149,313
|
4,977
|
C
|
Top
|
4
|
Dengue fever
|
119,180
|
3,972
|
FA
|
Top
|
5
|
Epstein–Barr virus
|
116,283
|
3,876
|
B
|
Top
|
6
|
HIV/AIDS
|
93,595
|
3,119
|
GA
|
Top
|
7
|
Rabies
|
90,124
|
3,004
|
B
|
Top
|
8
|
Respiratory syncytial virus
|
88,184
|
2,939
|
B
|
High
|
9
|
Prion
|
87,342
|
2,911
|
GA
|
Top
|
10
|
List of epidemics and pandemics
|
86,276
|
2,875
|
List
|
High
|
11
|
Shingles
|
79,852
|
2,661
|
GA
|
Top
|
12
|
Smallpox
|
79,842
|
2,661
|
GA
|
Top
|
13
|
Spanish flu
|
72,922
|
2,430
|
GA
|
Top
|
14
|
Human papillomavirus infection
|
69,407
|
2,313
|
B
|
Top
|
15
|
Canine parvovirus
|
68,642
|
2,288
|
B
|
Top
|
16
|
HIV
|
65,407
|
2,180
|
GA
|
Top
|
17
|
Molluscum contagiosum
|
60,756
|
2,025
|
B
|
High
|
18
|
Virus
|
56,014
|
1,867
|
FA
|
Top
|
19
|
Hodgkin lymphoma
|
53,530
|
1,784
|
B
|
Top
|
20
|
Creutzfeldt–Jakob disease
|
53,033
|
1,767
|
B
|
Top
|
21
|
Influenza A virus
|
52,325
|
1,744
|
B
|
Top
|
22
|
Herpes simplex virus
|
51,968
|
1,732
|
B
|
Top
|
23
|
Bell's palsy
|
51,101
|
1,703
|
B
|
Top
|
24
|
Hand, foot, and mouth disease
|
51,001
|
1,700
|
B
|
High
|
25
|
Infectious mononucleosis
|
50,368
|
1,678
|
B
|
Top
|
26
|
Chickenpox
|
49,690
|
1,656
|
B
|
Top
|
27
|
Polio
|
49,206
|
1,640
|
B
|
Top
|
28
|
Rotavirus
|
45,967
|
1,532
|
FA
|
Top
|
29
|
Gastroenteritis
|
45,647
|
1,521
|
GA
|
Top
|
30
|
Measles
|
43,589
|
1,452
|
B
|
Top
|
31
|
Herpes
|
42,594
|
1,419
|
GA
|
Top
|
32
|
COVID-19 pandemic in the United States
|
41,903
|
1,396
|
B
|
Low
|
33
|
Rhinovirus
|
41,021
|
1,367
|
C
|
High
|
34
|
Influenza A virus subtype H5N2
|
39,693
|
1,323
|
Start
|
Mid
|
35
|
Cytomegalovirus
|
39,439
|
1,314
|
B
|
Top
|
36
|
West Nile virus
|
37,283
|
1,242
|
B
|
High
|
37
|
SARS-CoV-2
|
35,243
|
1,174
|
B
|
Top
|
38
|
Canine distemper
|
33,105
|
1,103
|
B
|
Top
|
39
|
Hepatitis B
|
31,490
|
1,049
|
GA
|
Top
|
40
|
COVID-19 lab leak theory
|
31,378
|
1,045
|
C
|
Low
|
41
|
Variant Creutzfeldt–Jakob disease
|
31,268
|
1,042
|
B
|
High
|
42
|
Bacteriophage
|
30,983
|
1,032
|
B
|
Top
|
43
|
Influenza
|
30,757
|
1,025
|
FA
|
High
|
44
|
Hepatitis C
|
30,629
|
1,020
|
GA
|
Top
|
45
|
COVID-19 lockdown in India
|
30,038
|
1,001
|
B
|
Mid
|
46
|
Rosalind Franklin
|
29,928
|
997
|
B
|
High
|
47
|
Timeline of the COVID-19 pandemic
|
28,703
|
956
|
List
|
Top
|
48
|
Ebola
|
28,428
|
947
|
B
|
Top
|
49
|
COVID-19 vaccine
|
27,926
|
930
|
B
|
Top
|
50
|
Yellow fever
|
27,900
|
930
|
B
|
Top
|
51
|
Shope papilloma virus
|
27,744
|
924
|
C
|
Mid
|
52
|
Chronic wasting disease
|
27,173
|
905
|
C
|
Top
|
53
|
History of HIV/AIDS
|
26,915
|
897
|
B
|
Top
|
54
|
Varicella zoster virus
|
26,591
|
886
|
C
|
High
|
55
|
Coronavirus
|
25,753
|
858
|
C
|
High
|
56
|
Vaccine
|
25,700
|
856
|
B
|
Top
|
57
|
Mumps
|
24,626
|
820
|
B
|
Top
|
58
|
Zika virus
|
24,491
|
816
|
B
|
Top
|
59
|
HPV vaccine
|
24,377
|
812
|
B
|
High
|
60
|
Croup
|
23,709
|
790
|
GA
|
Top
|
61
|
Human metapneumovirus
|
22,288
|
742
|
C
|
High
|
62
|
Mpox
|
22,172
|
739
|
C
|
High
|
63
|
Common cold
|
21,974
|
732
|
GA
|
Top
|
64
|
Adenoviridae
|
21,719
|
723
|
B
|
High
|
65
|
Kaposi's sarcoma
|
21,363
|
712
|
C
|
Mid
|
66
|
Avian influenza
|
21,243
|
708
|
B
|
High
|
67
|
Rubella
|
21,195
|
706
|
B
|
Top
|
68
|
Gain-of-function research
|
20,858
|
695
|
Start
|
High
|
69
|
Origin of COVID-19
|
20,644
|
688
|
Start
|
Mid
|
70
|
Genital wart
|
19,978
|
665
|
B
|
Top
|
71
|
Feline leukemia virus
|
19,775
|
659
|
C
|
High
|
72
|
Influenza A virus subtype H5N1
|
19,341
|
644
|
B
|
Top
|
73
|
Epidemiology of HIV/AIDS
|
19,178
|
639
|
C
|
High
|
74
|
Pandemic
|
19,166
|
638
|
B
|
High
|
75
|
COVID-19 pandemic by country and territory
|
19,016
|
633
|
List
|
Top
|
76
|
HeLa
|
18,693
|
623
|
C
|
Mid
|
77
|
Genital herpes
|
18,196
|
606
|
C
|
High
|
78
|
COVID-19 pandemic in India
|
18,196
|
606
|
B
|
High
|
79
|
Chikungunya
|
17,894
|
596
|
B
|
High
|
80
|
Coxsackievirus
|
17,551
|
585
|
C
|
High
|
81
|
Edward Jenner
|
17,352
|
578
|
B
|
High
|
82
|
Sapovirus
|
17,259
|
575
|
C
|
High
|
83
|
Parvovirus B19
|
17,211
|
573
|
C
|
Mid
|
84
|
Cervical cancer
|
17,178
|
572
|
B
|
High
|
85
|
Foot-and-mouth disease
|
17,133
|
571
|
B
|
High
|
86
|
SARS-CoV-2 Omicron variant
|
16,983
|
566
|
C
|
High
|
87
|
2009 swine flu pandemic
|
16,977
|
565
|
GA
|
High
|
88
|
SARS
|
16,503
|
550
|
C
|
Top
|
89
|
Messenger RNA
|
15,906
|
530
|
C
|
High
|
90
|
Influenza A virus subtype H1N1
|
15,808
|
526
|
C
|
Top
|
91
|
COVID-19 lockdowns
|
15,755
|
525
|
B
|
Low
|
92
|
Cold sore
|
15,553
|
518
|
C
|
Top
|
93
|
Orthohantavirus
|
15,242
|
508
|
B
|
Top
|
94
|
Smallpox vaccine
|
15,216
|
507
|
B
|
Mid
|
95
|
List of deaths due to COVID-19
|
15,107
|
503
|
List
|
High
|
96
|
Remdesivir
|
14,883
|
496
|
C
|
High
|
97
|
Hepatitis A
|
14,844
|
494
|
B
|
Top
|
98
|
Enterovirus
|
14,806
|
493
|
C
|
High
|
99
|
Antiviral drug
|
14,401
|
480
|
C
|
Top
|
100
|
Amantadine
|
14,330
|
477
|
C
|
High
|
101
|
HIV/AIDS in the United States
|
14,301
|
476
|
C
|
Low
|
102
|
Human parainfluenza viruses
|
14,178
|
472
|
C
|
Mid
|
103
|
COVID-19 pandemic deaths
|
14,043
|
468
|
C
|
Low
|
104
|
Roseola
|
13,882
|
462
|
C
|
High
|
105
|
Influenza B virus
|
13,512
|
450
|
C
|
High
|
106
|
Feline immunodeficiency virus
|
13,413
|
447
|
C
|
High
|
107
|
Retrovirus
|
13,366
|
445
|
C
|
Top
|
108
|
List of COVID-19 vaccine authorizations
|
12,322
|
410
|
List
|
Mid
|
109
|
Varicella vaccine
|
12,281
|
409
|
B
|
Top
|
110
|
Marburg virus
|
12,024
|
400
|
C
|
High
|
111
|
COVID-19 misinformation
|
11,836
|
394
|
C
|
Low
|
112
|
2002–2004 SARS outbreak
|
11,745
|
391
|
B
|
Mid
|
113
|
Interferon
|
11,614
|
387
|
B
|
Top
|
114
|
Operation Warp Speed
|
11,587
|
386
|
C
|
High
|
115
|
Tick-borne encephalitis
|
11,300
|
376
|
Start
|
Low
|
116
|
Zidovudine
|
11,277
|
375
|
B
|
High
|
117
|
Dengue vaccine
|
11,239
|
374
|
C
|
Low
|
118
|
Herpesviridae
|
11,125
|
370
|
C
|
Top
|
119
|
Myxomatosis
|
11,097
|
369
|
GA
|
High
|
120
|
Wuhan Institute of Virology
|
10,715
|
357
|
C
|
Mid
|
121
|
Pithovirus
|
10,688
|
356
|
C
|
High
|
122
|
Rabies virus
|
10,541
|
351
|
C
|
Top
|
123
|
Moderna
|
10,203
|
340
|
C
|
Low
|
124
|
Timeline of the COVID-19 pandemic in the United States (2020)
|
10,169
|
338
|
C
|
Low
|
125
|
West Nile fever
|
9,857
|
328
|
C
|
High
|
126
|
COVID-19 pandemic in the United Kingdom
|
9,742
|
324
|
C
|
Low
|
127
|
Nipah virus
|
9,524
|
317
|
Start
|
Mid
|
128
|
Japanese encephalitis
|
9,503
|
316
|
B
|
High
|
129
|
Dengue virus
|
9,441
|
314
|
B
|
Top
|
130
|
SARS-CoV-1
|
9,365
|
312
|
C
|
High
|
131
|
Timeline of HIV/AIDS
|
9,351
|
311
|
List
|
Mid
|
132
|
Great Barrington Declaration
|
9,326
|
310
|
B
|
Low
|
133
|
Respiratory syncytial virus vaccine
|
9,201
|
306
|
B
|
Mid
|
134
|
Vaccination
|
9,180
|
306
|
B
|
Top
|
135
|
Rinderpest
|
9,092
|
303
|
B
|
High
|
136
|
Yellow fever vaccine
|
8,913
|
297
|
C
|
High
|
137
|
Gardasil
|
8,715
|
290
|
B
|
High
|
138
|
Compartmental models in epidemiology
|
8,628
|
287
|
C
|
Mid
|
139
|
Variants of SARS-CoV-2
|
8,568
|
285
|
C
|
Mid
|
140
|
Western African Ebola epidemic
|
8,249
|
274
|
GA
|
Mid
|
141
|
2020–2024 H5N1 outbreak
|
8,220
|
274
|
C
|
Low
|
142
|
DNA polymerase
|
8,179
|
272
|
C
|
Top
|
143
|
Tobacco mosaic virus
|
8,128
|
270
|
C
|
High
|
144
|
Rabies in animals
|
7,983
|
266
|
C
|
High
|
145
|
Virus classification
|
7,794
|
259
|
C
|
Top
|
146
|
Poliovirus
|
7,733
|
257
|
GA
|
High
|
147
|
Reverse transcriptase
|
7,677
|
255
|
B
|
Top
|
148
|
Human herpesvirus 6
|
7,639
|
254
|
C
|
High
|
149
|
Index case
|
7,560
|
252
|
Start
|
Low
|
150
|
Influenza vaccine
|
7,480
|
249
|
B
|
Top
|
151
|
Oropouche fever
|
7,449
|
248
|
C
|
Low
|
152
|
RNA interference
|
7,421
|
247
|
FA
|
High
|
153
|
Swine influenza
|
7,100
|
236
|
B
|
High
|
154
|
Crimean–Congo hemorrhagic fever
|
7,084
|
236
|
C
|
High
|
155
|
RNA virus
|
7,021
|
234
|
B
|
High
|
156
|
Subtypes of HIV
|
6,756
|
225
|
C
|
High
|
157
|
COVID-19 pandemic in Europe
|
6,735
|
224
|
C
|
Low
|
158
|
Feline calicivirus
|
6,734
|
224
|
C
|
Top
|
159
|
Viral disease
|
6,672
|
222
|
List
|
Top
|
160
|
Marburg virus disease
|
6,623
|
220
|
C
|
High
|
161
|
Ross River virus
|
6,574
|
219
|
C
|
Mid
|
162
|
Hantavirus pulmonary syndrome
|
6,565
|
218
|
Start
|
High
|
163
|
Zaire ebolavirus
|
6,565
|
218
|
C
|
Top
|
164
|
Merkel-cell carcinoma
|
6,556
|
218
|
C
|
Mid
|
165
|
Human T-lymphotropic virus 1
|
6,540
|
218
|
C
|
High
|
166
|
Virology
|
6,525
|
217
|
B
|
Top
|
167
|
Viroid
|
6,505
|
216
|
C
|
High
|
168
|
Peter Daszak
|
6,414
|
213
|
Start
|
Low
|
169
|
COVID-19 pandemic in Australia
|
6,381
|
212
|
B
|
Low
|
170
|
Measles vaccine
|
6,344
|
211
|
C
|
Low
|
171
|
Vaccine hesitancy
|
6,330
|
211
|
B
|
High
|
172
|
COVID-19 pandemic in the Philippines
|
6,301
|
210
|
B
|
Low
|
173
|
Parvoviridae
|
6,290
|
209
|
B
|
Mid
|
174
|
Orthomyxoviridae
|
6,244
|
208
|
B
|
High
|
175
|
Viral hemorrhagic fever
|
6,226
|
207
|
C
|
High
|
176
|
Host (biology)
|
6,212
|
207
|
GA
|
High
|
177
|
Hepatitis C virus
|
6,182
|
206
|
B
|
Top
|
178
|
Tomato yellow leaf curl virus
|
6,176
|
205
|
C
|
Low
|
179
|
COVID-19 vaccine misinformation and hesitancy
|
6,165
|
205
|
B
|
Top
|
180
|
Travel during the COVID-19 pandemic
|
6,133
|
204
|
C
|
Low
|
181
|
Henipavirus
|
6,032
|
201
|
C
|
High
|
182
|
Hepatitis B virus
|
5,935
|
197
|
C
|
Top
|
183
|
Severe acute respiratory syndrome coronavirus 2
|
5,917
|
197
|
Redirect
|
NA
|
184
|
Feline infectious peritonitis
|
5,875
|
195
|
C
|
High
|
185
|
Pod People (Invasion of the Body Snatchers)
|
5,874
|
195
|
Start
|
Low
|
186
|
Hong Kong flu
|
5,795
|
193
|
C
|
Low
|
187
|
Impact of the COVID-19 pandemic on cinema
|
5,789
|
192
|
B
|
Low
|
188
|
Attenuated vaccine
|
5,765
|
192
|
C
|
High
|
189
|
RNA polymerase
|
5,724
|
190
|
B
|
High
|
190
|
SV40
|
5,710
|
190
|
C
|
Mid
|
191
|
COVID-19 pandemic in mainland China
|
5,626
|
187
|
C
|
High
|
192
|
Carcinogenesis
|
5,606
|
186
|
B
|
Mid
|
193
|
Bioterrorism
|
5,552
|
185
|
B
|
Low
|
194
|
Powassan virus
|
5,494
|
183
|
C
|
Mid
|
195
|
Lentivirus
|
5,470
|
182
|
C
|
Mid
|
196
|
Lyssavirus
|
5,429
|
180
|
C
|
Mid
|
197
|
Phage therapy
|
5,413
|
180
|
C
|
Top
|
198
|
2022–2023 mpox outbreak
|
5,413
|
180
|
B
|
Mid
|
199
|
Oropouche orthobunyavirus
|
5,362
|
178
|
Start
|
Mid
|
200
|
Xenophobia and racism related to the COVID-19 pandemic
|
5,349
|
178
|
List
|
Low
|
201
|
COVID-19 pandemic in New Zealand
|
5,330
|
177
|
C
|
Low
|
202
|
History of COVID-19 vaccine development
|
5,327
|
177
|
C
|
Low
|
203
|
Polio eradication
|
5,313
|
177
|
B
|
Mid
|
204
|
MERS
|
5,278
|
175
|
B
|
High
|
205
|
Adeno-associated virus
|
5,212
|
173
|
B
|
High
|
206
|
Herpes simplex encephalitis
|
5,198
|
173
|
Start
|
Low
|
207
|
Malaysian movement control order
|
5,118
|
170
|
B
|
Low
|
208
|
Oncovirus
|
5,111
|
170
|
C
|
Top
|
209
|
Lady Mary Wortley Montagu
|
5,104
|
170
|
B
|
Low
|
210
|
2001 United Kingdom foot-and-mouth outbreak
|
5,042
|
168
|
C
|
Mid
|
211
|
Monkeypox virus
|
5,039
|
167
|
C
|
Mid
|
212
|
COVID-19 pandemic in Victoria
|
5,032
|
167
|
C
|
Low
|
213
|
Human polyomavirus 2
|
5,027
|
167
|
C
|
High
|
214
|
Solid lipid nanoparticle
|
5,025
|
167
|
C
|
Low
|
215
|
Rubella virus
|
5,021
|
167
|
C
|
High
|
216
|
COVID-19 pandemic in Canada
|
4,991
|
166
|
B
|
Mid
|
217
|
BK virus
|
4,973
|
165
|
B
|
Low
|
218
|
Impact of the COVID-19 pandemic on education
|
4,971
|
165
|
C
|
Low
|
219
|
Subacute sclerosing panencephalitis
|
4,966
|
165
|
C
|
Mid
|
220
|
Rotavirus vaccine
|
4,937
|
164
|
C
|
High
|
221
|
DNA virus
|
4,936
|
164
|
C
|
Top
|
222
|
Papillomaviridae
|
4,908
|
163
|
B
|
Top
|
223
|
Cowpox
|
4,886
|
162
|
C
|
Mid
|
224
|
Metagenomics
|
4,826
|
160
|
GA
|
High
|
225
|
Incertae sedis
|
4,823
|
160
|
C
|
Low
|
226
|
Viral envelope
|
4,757
|
158
|
Start
|
Top
|
227
|
Transduction (genetics)
|
4,728
|
157
|
C
|
High
|
228
|
Molnupiravir
|
4,727
|
157
|
C
|
Mid
|
229
|
Flavivirus
|
4,700
|
156
|
B
|
High
|
230
|
Zika fever
|
4,680
|
156
|
B
|
High
|
231
|
Timeline of the COVID-19 pandemic in 2019
|
4,662
|
155
|
List
|
High
|
232
|
Lysogenic cycle
|
4,647
|
154
|
C
|
High
|
233
|
COVID-19 vaccination in India
|
4,631
|
154
|
C
|
Low
|
234
|
Poxviridae
|
4,630
|
154
|
C
|
High
|
235
|
Hepatitis E
|
4,607
|
153
|
GA
|
High
|
236
|
Hammer-headed bat
|
4,577
|
152
|
GA
|
Low
|
237
|
Hershey–Chase experiment
|
4,570
|
152
|
C
|
Mid
|
238
|
List of films impacted by the COVID-19 pandemic
|
4,531
|
151
|
List
|
Mid
|
239
|
Influenza pandemic
|
4,508
|
150
|
B
|
Top
|
240
|
White House Coronavirus Task Force
|
4,488
|
149
|
C
|
Low
|
241
|
Variolation
|
4,464
|
148
|
C
|
High
|
242
|
Pandemic H1N1/09 virus
|
4,453
|
148
|
C
|
Mid
|
243
|
Viral replication
|
4,433
|
147
|
C
|
Top
|
244
|
Capsid
|
4,416
|
147
|
C
|
Top
|
245
|
COVID-19 pandemic in Italy
|
4,416
|
147
|
C
|
Mid
|
246
|
Kaposi's sarcoma-associated herpesvirus
|
4,411
|
147
|
C
|
High
|
247
|
History of smallpox
|
4,399
|
146
|
C
|
Mid
|
248
|
Viral hepatitis
|
4,386
|
146
|
C
|
High
|
249
|
Lambda phage
|
4,374
|
145
|
B
|
High
|
250
|
Giant virus
|
4,307
|
143
|
C
|
High
|
251
|
MERS-related coronavirus
|
4,277
|
142
|
B
|
High
|
252
|
Epstein–Barr virus–associated lymphoproliferative diseases
|
4,256
|
141
|
C
|
Mid
|
253
|
Baltimore classification
|
4,249
|
141
|
B
|
Top
|
254
|
COVID-19 pandemic in Hubei
|
4,212
|
140
|
C
|
Mid
|
255
|
Virulence
|
4,181
|
139
|
C
|
High
|
256
|
Economic impact of the COVID-19 pandemic
|
4,168
|
138
|
B
|
Low
|
257
|
Walter Reed
|
4,148
|
138
|
C
|
Low
|
258
|
Lassa fever
|
4,145
|
138
|
C
|
High
|
259
|
Diagnosis of HIV/AIDS
|
4,134
|
137
|
B
|
High
|
260
|
Nipah virus infection
|
4,097
|
136
|
C
|
High
|
261
|
COVID-19 pandemic in North Korea
|
4,097
|
136
|
B
|
Mid
|
262
|
COVID-19 pandemic in the Republic of Ireland
|
4,069
|
135
|
C
|
Low
|
263
|
HBsAg
|
4,067
|
135
|
Start
|
High
|
264
|
Simian immunodeficiency virus
|
4,052
|
135
|
C
|
High
|
265
|
COVID-19 vaccination in the United States
|
4,052
|
135
|
Start
|
Low
|
266
|
Adenovirus infection
|
4,044
|
134
|
Start
|
Mid
|
267
|
Marek's disease
|
4,028
|
134
|
C
|
Mid
|
268
|
1889–1890 pandemic
|
4,017
|
133
|
C
|
Mid
|
269
|
Hepatitis D
|
4,002
|
133
|
C
|
Mid
|
270
|
Face masks during the COVID-19 pandemic
|
3,960
|
132
|
B
|
Low
|
271
|
Escherichia virus T4
|
3,946
|
131
|
Start
|
Mid
|
272
|
Ebolavirus
|
3,905
|
130
|
C
|
Mid
|
273
|
H5N1 vaccine
|
3,868
|
128
|
C
|
Low
|
274
|
1977 Russian flu
|
3,868
|
128
|
C
|
Mid
|
275
|
Disease X
|
3,858
|
128
|
GA
|
Low
|
276
|
B virus
|
3,840
|
128
|
C
|
Mid
|
277
|
RNA-dependent RNA polymerase
|
3,834
|
127
|
C
|
Top
|
278
|
COVID-19 pandemic in New South Wales
|
3,833
|
127
|
B
|
Low
|
279
|
Spike protein
|
3,773
|
125
|
Start
|
Low
|
280
|
SARS-CoV-2 Delta variant
|
3,753
|
125
|
C
|
Mid
|
281
|
Picornavirus
|
3,738
|
124
|
B
|
Mid
|
282
|
1978 smallpox outbreak in the United Kingdom
|
3,722
|
124
|
B
|
Low
|
283
|
COVID-19 pandemic on cruise ships
|
3,695
|
123
|
B
|
High
|
284
|
Positive-strand RNA virus
|
3,686
|
122
|
C
|
High
|
285
|
Phage display
|
3,678
|
122
|
C
|
Mid
|
286
|
Shi Zhengli
|
3,677
|
122
|
Start
|
Low
|
287
|
COVID-19 pandemic in Germany
|
3,655
|
121
|
C
|
Low
|
288
|
Rabbit hemorrhagic disease
|
3,647
|
121
|
B
|
Mid
|
289
|
COVID-19 pandemic in Japan
|
3,633
|
121
|
C
|
Low
|
290
|
Echovirus
|
3,627
|
120
|
List
|
Mid
|
291
|
COVID-19 pandemic in California
|
3,616
|
120
|
C
|
Mid
|
292
|
Non-cellular life
|
3,605
|
120
|
Start
|
Low
|
293
|
Strain (biology)
|
3,568
|
118
|
C
|
High
|
294
|
COVID-19 pandemic in Singapore
|
3,559
|
118
|
B
|
High
|
295
|
Endogenous retrovirus
|
3,538
|
117
|
C
|
Mid
|
296
|
Sense (molecular biology)
|
3,535
|
117
|
C
|
High
|
297
|
Measles morbillivirus
|
3,496
|
116
|
C
|
Top
|
298
|
Lytic cycle
|
3,475
|
115
|
C
|
High
|
299
|
African swine fever virus
|
3,458
|
115
|
C
|
High
|
300
|
Viral encephalitis
|
3,456
|
115
|
B
|
High
|
301
|
COVID-19 vaccination mandates in the United States
|
3,427
|
114
|
Start
|
Low
|
302
|
HIV vaccine development
|
3,408
|
113
|
C
|
Mid
|
303
|
Australian bat lyssavirus
|
3,398
|
113
|
C
|
Low
|
304
|
Inclusion bodies
|
3,398
|
113
|
C
|
High
|
305
|
Symptoms of COVID-19
|
3,386
|
112
|
C
|
Low
|
306
|
Human alphaherpesvirus 2
|
3,366
|
112
|
Start
|
Mid
|
307
|
Richard H. Ebright
|
3,365
|
112
|
Start
|
Mid
|
308
|
1957–1958 influenza pandemic
|
3,355
|
111
|
C
|
Mid
|
309
|
GS-441524
|
3,348
|
111
|
Start
|
Low
|
310
|
Coronavirus spike protein
|
3,313
|
110
|
Start
|
Low
|
311
|
COVID-19 pandemic in New York City
|
3,288
|
109
|
Start
|
Low
|
312
|
Ebola virus cases in the United States
|
3,286
|
109
|
C
|
High
|
313
|
COVID-19 pandemic in Maharashtra
|
3,271
|
109
|
C
|
Low
|
314
|
Human alphaherpesvirus 1
|
3,236
|
107
|
Start
|
Mid
|
315
|
Arbovirus
|
3,221
|
107
|
C
|
Top
|
316
|
Vaccinia
|
3,186
|
106
|
C
|
High
|
317
|
Virgin cleansing myth
|
3,179
|
105
|
Start
|
Low
|
318
|
Paramyxoviridae
|
3,177
|
105
|
C
|
High
|
319
|
Orthopoxvirus
|
3,145
|
104
|
C
|
High
|
320
|
Impact of the COVID-19 pandemic on commercial air transport
|
3,120
|
104
|
C
|
Low
|
321
|
Human mortality from H5N1
|
3,117
|
103
|
C
|
High
|
322
|
HIV trial in Libya
|
3,112
|
103
|
B
|
Low
|
323
|
COVID-19 pandemic on Diamond Princess
|
3,105
|
103
|
Start
|
Low
|
324
|
Negative-strand RNA virus
|
3,081
|
102
|
B
|
Mid
|
325
|
Rhabdoviridae
|
3,002
|
100
|
C
|
High
|
326
|
Timeline of the COVID-19 pandemic in Canada
|
2,991
|
99
|
B
|
Mid
|
327
|
COVID-19 pandemic in Malaysia
|
2,986
|
99
|
B
|
High
|
328
|
Ebola vaccine
|
2,976
|
99
|
C
|
Mid
|
329
|
Global spread of H5N1
|
2,942
|
98
|
B
|
High
|
330
|
Structure and genome of HIV
|
2,881
|
96
|
B
|
High
|
331
|
Koplik's spots
|
2,874
|
95
|
C
|
Mid
|
332
|
Ivermectin during the COVID-19 pandemic
|
2,873
|
95
|
B
|
Low
|
333
|
Flat wart
|
2,846
|
94
|
Stub
|
Mid
|
334
|
Eastern equine encephalitis
|
2,841
|
94
|
C
|
Mid
|
335
|
Astrovirus
|
2,827
|
94
|
B
|
Low
|
336
|
List of unproven methods against COVID-19
|
2,827
|
94
|
List
|
Mid
|
337
|
COVID-19 lockdown in China
|
2,808
|
93
|
C
|
High
|
338
|
Impact of the COVID-19 pandemic on the environment
|
2,788
|
92
|
C
|
Low
|
339
|
Rolling circle replication
|
2,777
|
92
|
C
|
Mid
|
340
|
Viral evolution
|
2,761
|
92
|
C
|
High
|
341
|
Feline coronavirus
|
2,757
|
91
|
C
|
Mid
|
342
|
Invertebrate iridescent virus 31
|
2,756
|
91
|
Start
|
Low
|
343
|
Congenital rubella syndrome
|
2,751
|
91
|
Start
|
Mid
|
344
|
Antibody-dependent enhancement
|
2,734
|
91
|
C
|
High
|
345
|
Natural reservoir
|
2,724
|
90
|
C
|
High
|
346
|
Human betaherpesvirus 5
|
2,715
|
90
|
C
|
High
|
347
|
Hendra virus
|
2,704
|
90
|
Start
|
Mid
|
348
|
COVID-19 pandemic in Russia
|
2,688
|
89
|
C
|
Low
|
349
|
Impact of the COVID-19 pandemic on sports
|
2,685
|
89
|
C
|
Mid
|
350
|
Bluetongue disease
|
2,652
|
88
|
B
|
High
|
351
|
History of virology
|
2,648
|
88
|
B
|
Top
|
352
|
Impact of the COVID-19 pandemic on the video game industry
|
2,648
|
88
|
C
|
Low
|
353
|
Spillover infection
|
2,647
|
88
|
Start
|
Mid
|
354
|
Intracellular parasite
|
2,641
|
88
|
Start
|
Mid
|
355
|
Carnivore protoparvovirus 1
|
2,617
|
87
|
Start
|
Mid
|
356
|
Viral pneumonia
|
2,605
|
86
|
Start
|
High
|
357
|
Heterophile antibody test
|
2,604
|
86
|
C
|
Low
|
358
|
COVID-19 pandemic in Sweden
|
2,603
|
86
|
B
|
Low
|
359
|
List of biosafety level 4 organisms
|
2,588
|
86
|
List
|
Low
|
360
|
Timeline of human vaccines
|
2,573
|
85
|
List
|
Low
|
361
|
Lamivudine
|
2,563
|
85
|
C
|
Mid
|
362
|
Political impact of the COVID-19 pandemic
|
2,559
|
85
|
B
|
Low
|
363
|
Molluscum contagiosum virus
|
2,552
|
85
|
C
|
Mid
|
364
|
Viral vector vaccine
|
2,538
|
84
|
Start
|
Low
|
365
|
Human coronavirus OC43
|
2,532
|
84
|
C
|
Mid
|
366
|
Coxsackie A virus
|
2,514
|
83
|
Start
|
Mid
|
367
|
DNA vaccine
|
2,511
|
83
|
Start
|
Low
|
368
|
Viral shedding
|
2,508
|
83
|
Start
|
High
|
369
|
Conjugate vaccine
|
2,498
|
83
|
C
|
High
|
370
|
Coxsackie B virus
|
2,494
|
83
|
C
|
Mid
|
371
|
List of Ebola outbreaks
|
2,494
|
83
|
List
|
Low
|
372
|
Caliciviridae
|
2,490
|
83
|
C
|
Mid
|
373
|
Pleomorphism (microbiology)
|
2,488
|
82
|
C
|
High
|
374
|
SARS-related coronavirus
|
2,480
|
82
|
C
|
High
|
375
|
Face masks during the COVID-19 pandemic in the United States
|
2,477
|
82
|
C
|
Low
|
376
|
Vaccine shedding
|
2,442
|
81
|
Start
|
Mid
|
377
|
Timeline of the COVID-19 pandemic in January 2020
|
2,442
|
81
|
List
|
High
|
378
|
Rift Valley fever
|
2,441
|
81
|
C
|
High
|
379
|
PEGylation
|
2,431
|
81
|
C
|
Low
|
380
|
Discrimination against people with HIV/AIDS
|
2,407
|
80
|
C
|
High
|
381
|
COVID-19 testing
|
2,401
|
80
|
B
|
Low
|
382
|
U.S. state and local government responses to the COVID-19 pandemic
|
2,399
|
79
|
C
|
Mid
|
383
|
SARS-CoV-2 Alpha variant
|
2,386
|
79
|
C
|
Low
|
384
|
Vertically transmitted infection
|
2,381
|
79
|
C
|
High
|
385
|
Bat virome
|
2,373
|
79
|
GA
|
High
|
386
|
Reverse-transcriptase inhibitor
|
2,363
|
78
|
C
|
High
|
387
|
Virulent Newcastle disease
|
2,355
|
78
|
C
|
High
|
388
|
Polyomaviridae
|
2,354
|
78
|
C
|
High
|
389
|
Influenza A virus subtype H9N2
|
2,352
|
78
|
Start
|
Mid
|
390
|
Cache Valley orthobunyavirus
|
2,352
|
78
|
C
|
Low
|
391
|
COVID-19 pandemic in Tamil Nadu
|
2,352
|
78
|
C
|
Low
|
392
|
Mumps virus
|
2,348
|
78
|
B
|
High
|
393
|
Riboviria
|
2,347
|
78
|
B
|
Top
|
394
|
Primate T-lymphotropic virus
|
2,346
|
78
|
C
|
High
|
395
|
Jonathan Van-Tam
|
2,335
|
77
|
C
|
Low
|
396
|
Superinfection
|
2,333
|
77
|
Stub
|
Mid
|
397
|
Innate resistance to HIV
|
2,332
|
77
|
C
|
High
|
398
|
COVID-19 pandemic in South Africa
|
2,285
|
76
|
B
|
Mid
|
399
|
Filoviridae
|
2,284
|
76
|
Start
|
High
|
400
|
Influenza A virus subtype H3N2
|
2,282
|
76
|
C
|
High
|
401
|
White House COVID-19 outbreak
|
2,274
|
75
|
C
|
Low
|
402
|
Plant virus
|
2,254
|
75
|
C
|
Top
|
403
|
Virus latency
|
2,254
|
75
|
C
|
High
|
404
|
Negri body
|
2,251
|
75
|
Start
|
Mid
|
405
|
Equine infectious anemia
|
2,250
|
75
|
Start
|
Mid
|
406
|
Alphavirus
|
2,244
|
74
|
B
|
Mid
|
407
|
Hantavirus hemorrhagic fever with renal syndrome
|
2,234
|
74
|
Start
|
High
|
408
|
2020–21 Singapore circuit breaker measures
|
2,223
|
74
|
C
|
Low
|
409
|
U.S. federal government response to the COVID-19 pandemic
|
2,223
|
74
|
C
|
Mid
|
410
|
Deployment of COVID-19 vaccines
|
2,220
|
74
|
C
|
High
|
411
|
Flaviviridae
|
2,204
|
73
|
Start
|
High
|
412
|
Timeline of the COVID-19 pandemic in March 2020
|
2,190
|
73
|
List
|
High
|
413
|
Timeline of the COVID-19 pandemic in New Zealand (2020)
|
2,190
|
73
|
List
|
Low
|
414
|
Mimivirus
|
2,178
|
72
|
C
|
Mid
|
415
|
COVID-19 pandemic in North America
|
2,141
|
71
|
C
|
Mid
|
416
|
COVID-19 pandemic in South Korea
|
2,130
|
71
|
B
|
Low
|
417
|
Banana bunchy top virus
|
2,129
|
70
|
C
|
Mid
|
418
|
Oncolytic virus
|
2,123
|
70
|
B
|
Mid
|
419
|
Eczema herpeticum
|
2,096
|
69
|
Start
|
Low
|
420
|
History of coronavirus
|
2,091
|
69
|
B
|
Mid
|
421
|
Ebola virus
|
2,081
|
69
|
Redirect
|
NA
|
422
|
Kyasanur Forest disease
|
2,075
|
69
|
B
|
Mid
|
423
|
Lassa mammarenavirus
|
2,067
|
68
|
Start
|
Mid
|
424
|
List of diseases of the honey bee
|
2,066
|
68
|
List
|
High
|
425
|
Emerging infectious disease
|
2,066
|
68
|
Start
|
Low
|
426
|
Lymphocytic choriomeningitis
|
2,065
|
68
|
C
|
Mid
|
427
|
2015–16 Zika virus epidemic
|
2,064
|
68
|
B
|
Mid
|
428
|
FFP standards
|
2,050
|
68
|
C
|
Mid
|
429
|
Transmission of COVID-19
|
2,047
|
68
|
C
|
High
|
430
|
Double-stranded RNA viruses
|
2,044
|
68
|
Start
|
High
|
431
|
Chinese government response to COVID-19
|
2,031
|
67
|
B
|
Mid
|
432
|
HIV superinfection
|
2,000
|
66
|
C
|
Mid
|
433
|
COVID-19 pandemic in France
|
1,985
|
66
|
B
|
Mid
|
434
|
Tick-borne encephalitis virus
|
1,977
|
65
|
C
|
High
|
435
|
Human betaherpesvirus 7
|
1,966
|
65
|
C
|
Mid
|
436
|
New York COVID-19 nursing home scandal
|
1,964
|
65
|
B
|
Low
|
437
|
HA-tag
|
1,955
|
65
|
Start
|
High
|
438
|
COVID-19 pandemic in Hong Kong
|
1,938
|
64
|
C
|
Low
|
439
|
Ross River fever
|
1,929
|
64
|
B
|
Mid
|
440
|
Psittacine beak and feather disease
|
1,922
|
64
|
Start
|
Mid
|
441
|
Cytopathic effect
|
1,921
|
64
|
C
|
High
|
442
|
COVID-19 pandemic in New York (state)
|
1,919
|
63
|
C
|
Low
|
443
|
Timeline of the COVID-19 pandemic in New Zealand (2021)
|
1,919
|
63
|
List
|
Low
|
444
|
Lumpy skin disease
|
1,908
|
63
|
C
|
Mid
|
445
|
HIV/AIDS in Russia
|
1,907
|
63
|
Start
|
Low
|
446
|
1793 Philadelphia yellow fever epidemic
|
1,889
|
62
|
C
|
Low
|
447
|
Baculoviridae
|
1,883
|
62
|
C
|
Mid
|
448
|
Metapneumovirus
|
1,878
|
62
|
Stub
|
Mid
|
449
|
Koilocyte
|
1,875
|
62
|
Start
|
Low
|
450
|
Bunyavirales
|
1,872
|
62
|
C
|
Mid
|
451
|
COVID-19 pandemic in Pakistan
|
1,862
|
62
|
B
|
Low
|
452
|
Superspreading event
|
1,851
|
61
|
C
|
High
|
453
|
Feline viral rhinotracheitis
|
1,846
|
61
|
C
|
Top
|
454
|
Arenavirus
|
1,845
|
61
|
C
|
High
|
455
|
Swedish government response to the COVID-19 pandemic
|
1,845
|
61
|
C
|
Low
|
456
|
Orf (disease)
|
1,843
|
61
|
Start
|
Low
|
457
|
White House COVID-19 Response Team
|
1,840
|
61
|
List
|
Low
|
458
|
Bacteriophage MS2
|
1,839
|
61
|
Start
|
Mid
|
459
|
Human coronavirus NL63
|
1,831
|
61
|
C
|
Low
|
460
|
Obelisk (biology)
|
1,831
|
61
|
Unknown
|
High
|
461
|
Orthornavirae
|
1,829
|
60
|
B
|
High
|
462
|
Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2020)
|
1,819
|
60
|
List
|
Low
|
463
|
Adenovirus serotype 36
|
1,812
|
60
|
Start
|
Mid
|
464
|
Fowlpox
|
1,806
|
60
|
Start
|
Low
|
465
|
Feline spongiform encephalopathy
|
1,800
|
60
|
Start
|
Low
|
466
|
COVID-19 vaccination in the United Kingdom
|
1,799
|
59
|
C
|
Low
|
467
|
HIV/AIDS in Thailand
|
1,796
|
59
|
Start
|
Low
|
468
|
Coronaviridae
|
1,783
|
59
|
Start
|
High
|
469
|
HIV/AIDS in the Philippines
|
1,779
|
59
|
Start
|
Low
|
470
|
Lentiviral vector in gene therapy
|
1,773
|
59
|
C
|
Low
|
471
|
Chimera (virus)
|
1,766
|
58
|
Start
|
High
|
472
|
M13 bacteriophage
|
1,762
|
58
|
Start
|
Mid
|
473
|
Pandoravirus
|
1,761
|
58
|
Start
|
High
|
474
|
Hosta virus X
|
1,741
|
58
|
Start
|
Low
|
475
|
COVID-19 misinformation by the United States
|
1,733
|
57
|
C
|
Low
|
476
|
Nanoparticle drug delivery
|
1,719
|
57
|
C
|
Low
|
477
|
Viral load
|
1,717
|
57
|
Start
|
Mid
|
478
|
1976 Zaire Ebola virus outbreak
|
1,717
|
57
|
C
|
Low
|
479
|
Sedoreoviridae
|
1,710
|
57
|
C
|
Mid
|
480
|
MOG antibody disease
|
1,704
|
56
|
C
|
Mid
|
481
|
COVID-19 pandemic in Kerala
|
1,703
|
56
|
C
|
Low
|
482
|
T7 RNA polymerase
|
1,701
|
56
|
Start
|
Low
|
483
|
List of pests and diseases of roses
|
1,688
|
56
|
List
|
Mid
|
484
|
List of virus species
|
1,673
|
55
|
List
|
Top
|
485
|
Cucumber mosaic virus
|
1,671
|
55
|
C
|
Mid
|
486
|
Mosaic virus
|
1,665
|
55
|
List
|
Mid
|
487
|
Cervarix
|
1,660
|
55
|
C
|
Mid
|
488
|
Timeline of the COVID-19 pandemic in New York City
|
1,641
|
54
|
Start
|
Low
|
489
|
History of the COVID-19 pandemic in the United Kingdom
|
1,640
|
54
|
C
|
High
|
490
|
Hemagglutinin (influenza)
|
1,631
|
54
|
C
|
High
|
491
|
British government response to the COVID-19 pandemic
|
1,630
|
54
|
C
|
Low
|
492
|
Communication of the Trump administration during the COVID-19 pandemic
|
1,621
|
54
|
C
|
Low
|
493
|
Reston virus
|
1,605
|
53
|
C
|
Low
|
494
|
Infectious bursal disease
|
1,594
|
53
|
Start
|
Mid
|
495
|
Feed a cold, starve a fever
|
1,591
|
53
|
C
|
Low
|
496
|
Jeremy Farrar
|
1,583
|
52
|
C
|
Low
|
497
|
Pigeon pox
|
1,578
|
52
|
Stub
|
Low
|
498
|
COVID-19 pandemic in Gujarat
|
1,573
|
52
|
Start
|
Low
|
499
|
COVID-19 pandemic in Mexico
|
1,548
|
51
|
C
|
Low
|
500
|
Black flying fox
|
1,547
|
51
|
C
|
Mid
|